Medtronic InSync Panel OK May Presage September FDA Approval

The Circulatory System Devices Panel's approvable recommendation for Medtronic's InSync pacing system sets the stage for FDA final sign-off by Sept. 30, the last day of the federal fiscal year.

More from Archive

More from Medtech Insight